Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Tenon Medical, Inc. (TNON : NSDQ)

• Company Description    Tenon Medical Inc. is a medical device company which developed a proprietary, U.S. Food and Drug Administration cleared surgical implant system for sacroiliac joint fixation/fusion surgery. Tenon Medical Inc. is based in LOS GATOS, CA. Number of Employees: 26

• Price / Volume Information    Yesterday's Closing Price: $3.36 Daily Weekly Monthly 20 Day Moving Average: 3,656,907 shares Shares Outstanding: 0.67 (millions) Market Capitalization: $2.24 (millions) Beta: 1.36 52 Week High: $50.40 52 Week Low: $3.18 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -45.28% -44.89% 12 Week -84.07% -84.41% Year To Date -89.90% -90.99%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 104 COOPER COURT - LOS GATOS,CA 95032 USA ph: 408-649-5760 fax: - tenon@mzgroup.us http://www.tenonmed.com

• General Corporate Information    Officers Steven M. Foster - Chief Executive Officer and President; Director Richard Ferrari - Executive Chairman of the Board Kevin Williamson - Chief Financial Officer; Secretary Richard Ginn - Chief Operations Officer and Director Ivan Howard - Director Peer Information Tenon Medical, Inc. (ABMD) Tenon Medical, Inc. (DMDS) Tenon Medical, Inc. (CPWY.) Tenon Medical, Inc. (EQUR) Tenon Medical, Inc. (ECIA) Tenon Medical, Inc. (FMS) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED INSTRUMENTS Sector: Medical CUSIP: 88066N402 SIC: 3841 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/26 Next Expected EPS Date: 11/12/26 Share - Related Items Shares Outstanding: 0.67 Most Recent Split Date: 8.00 (0.03:1) Beta: 1.36 Market Capitalization: $2.24 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/12/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: - Price / Sales: 0.42 EPS Growth vs. Year Ago Period: 1.88% vs. Previous Quarter: -13.94% Sales Growth vs. Year Ago Period: 126.77% vs. Previous Quarter: -7.25% ROE 06/30/26 - - 03/31/26 - -907.60 12/31/25 - -409.16 ROA 06/30/26 - -124.84 03/31/26 - -110.17 12/31/25 - -110.06 Current Ratio 06/30/26 - 0.58 03/31/26 - 1.03 12/31/25 - 2.11 Quick Ratio 06/30/26 - 0.48 03/31/26 - 0.92 12/31/25 - 1.78 Operating Margin 06/30/26 - -257.85 03/31/26 - -270.09 12/31/25 - -318.36 Net Margin 06/30/26 - -257.85 03/31/26 - -270.09 12/31/25 - -318.36 Pre-Tax Margin 06/30/26 - -257.85 03/31/26 - -270.09 12/31/25 - -318.36 Book Value 06/30/26 - -14.57 03/31/26 - -3.65 12/31/25 - 6.19 Inventory Turnover 06/30/26 - 1.76 03/31/26 - 1.65 12/31/25 - 1.71 Debt-to-Equity 06/30/26 - - 03/31/26 - - 12/31/25 - 0.00 Debt-to-Capital 06/30/26 - - 03/31/26 - 0.00 12/31/25 - 0.00

Powered by Zacks Investment Research ©